Avenacy Announces Launch of Prochlorperazine Edisylate Injection, USP in the U.S. Market [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
SCHAUMBURG, Ill., June 26, 2024 BUSINESS WIRE )--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Prochlorperazine Edisylate Injection, USP in the United States as a therapeutic generic equivalent for COMPAZINE ® as approved by the U.S. Food and Drug Administration. Prochlorperazine Edisylate Injection, USP is indicated to control severe nausea and vomiting and for the treatment of schizophrenia. Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation. Avenacy's Prochlorperazine Edisylate Injection, USP is available in 10 mg/2 mL (5 mg per mL) 10-pack multi-dose vials. In line with Avenacy's mission to champion patient safety and streamline patient care, Prochlorperazine Edisylate Injection, USP will feature the Company's highly differentiated packaging and labeling to support accurate medication selection. Avenacy will begin shi
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Artificial Intelligence (AI) in Medical Writing Market Research Report 2024: Global Forecast to 2028 and 2033 Featuring Major Players - IBM, IQVIA, Icon, Syneos Health, and Parexel [Yahoo! Finance]Yahoo! Finance
- IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock Right Now [Yahoo! Finance]Yahoo! Finance
- Leading Artificial Intelligence (AI) Companies in Clinical Trials [Yahoo! Finance]Yahoo! Finance
- IQVIA Holdings Inc. (NYSE: IQV) had its price target raised by analysts at Robert W. Baird from $251.00 to $256.00. They now have a "neutral" rating on the stock.MarketBeat
- India Clinical Trials Market By Region, Competition, Forecast & Opportunities, 2020-2024 & 2024-2030 [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 7/22/24 - Beat
IQV
Sec Filings
- 8/29/24 - Form 4
- 8/27/24 - Form 144
- 8/15/24 - Form SC
- IQV's page on the SEC website